Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Sedar entry at 845 am

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Nov 18, 2021 5:57pm

509 Views

Post# 34143131

RE:Sedar entry at 845 am

I found Project Number 3226110 in the OSC Bulletin of June 3, 2021 It's on page 112 of the pdf - numbered on the page as 4824.

_______________________________________________

Issuer Name:

Theralase Technologies Inc.

Principal Regulator - Ontario

Type and Date:

Preliminary Shelf Prospectus dated May 21, 2021

NP 11-202 Preliminary Receipt dated May 25, 2021

Offering Price and Description:

$100,000,000.00 - Common Shares, Warrants, Units,

Subscription Receipts

Underwriter(s) or Distributor(s):

-

Promoter(s):

-

Project #3226110
______________________________________

So this is related to the $100,000,000 preliminary short form prospectus which was posted on sedar on May 21 (the Final Shelf Prospectus of June 28 was not posted on sedar). Looks like it was withdrawn yesterday.

cashascars wrote:
ISSUER:

Theralase Technologies Inc. Principal Jurisdiction - Ontario

DATES:

Final Shelf Prospectus dated June 28, 2021 Withdrawn on November 17, 2021

PROJECT NUMBER:

3226110

Does anyone understand what this is about?
Thanks in advance.
Good times ahead I hope.
cashascars